Table 1.
Relative ROI size between hemispheres (ratio of ipsilesional to contralesional surface area) for patients JS and PF and a healthy control (C1).
| ROI | JS I/C 0–3 mo |
JS I/C 3–8 mo |
JS I/C 8–11 mo |
PF I/C 0–3 mo |
PF I/C 0–7 mo |
C1 RH/LH 0 mo |
C1 RH/LH 0–6 mo |
|---|---|---|---|---|---|---|---|
| V1 | 0.37 | 0.48 | 0.52 | 0.88 | 1.71 | 0.78 | 0.83 |
| V2v | 0.19 | 0.17 | 0.52 | 0.08 | 0.08 | 0.95 | 0.92 |
| V2d | 0.58 | 0.59 | 0.74 | 0.62 | 1.66 | 1.28 | 1.29 |
| V3v/VP | 0.21 | 0.40 | 0.48 | 1.31 | 0.84 | 0.92 | 0.96 |
| V3 | 0.94 | 0.61 | 0.38 | 1.12 | 0.74 | 1.38 | 1.30 |
| V3a | 1.57 | 1.50 | 0.79 | 0.92 | 0.98 | 0.98 | 1.12 |
| V4 | 0.85 | 0.75 | 0.66 | 1.45 | 1.30 | 1.16 | 1.21 |
| MT+ | 0.90 | 0.89 | 0.64 | 0.90 | 0.96 | 0.64 | 0.66 |